Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Naratriptan
Drug ID BADD_D01535
Description Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
Indications and Usage For the acute treatment of migraine attacks with or without aura in adults.
Marketing Status approved; investigational
ATC Code N02CC02
DrugBank ID DB00952
KEGG ID D08255
MeSH ID C106783
PubChem ID 4440
TTD Drug ID D0T3KI
NDC Product Code 69452-340; 69452-341; 23155-054; 42043-130; 42043-131; 23155-055; 50090-6162; 0054-0278; 0054-0279
UNII QX3KXL1ZA2
Synonyms naratriptan | N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide | GR 85548A | naratriptan hydrochloride | N-methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide monohydrochloride | 1H-indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride | Naramig | Amerge | Colatan
Chemical Information
Molecular Formula C17H25N3O2S
CAS Registry Number 121679-13-8
SMILES CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001---
Abnormal dreams17.15.02.001; 19.02.03.001---
Acne23.02.01.001---
Aggression19.05.01.001---
Agitation17.02.05.012; 19.06.02.001--
Alopecia23.02.02.001--
Altered state of consciousness17.02.04.001; 19.07.01.003---
Anaemia01.03.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Anaphylactoid reaction10.01.07.003; 24.06.03.007---
Angina pectoris02.02.02.002; 24.04.04.002--
Anxiety19.06.02.0020.003367%
Aphasia17.02.03.001; 19.21.01.001--
Arrhythmia02.03.02.001---
Arteriospasm coronary02.02.02.005; 12.02.01.031; 24.04.04.005---
Arthralgia15.01.02.001--
Asthenia08.01.01.001---
Asthma10.01.03.010; 22.03.01.002---
Atrial fibrillation02.03.03.002--
Atrial flutter02.03.03.003--
Biopsy endometrium abnormal13.20.02.002---
Bladder pain20.02.02.001---
Blood pressure increased13.14.03.005---
Body temperature increased13.15.01.001---
Bone pain15.02.01.001--
Bradycardia02.03.02.002---
Breast discharge21.05.05.001---
Breast inflammation21.05.03.001---
Breast mass21.05.04.002---
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages